In-vivo antimalarial activity of some oxygenated xanthones

Annals of Tropical Medicine and Parasitology

Volumn 97, Issue 7, 2003, Pages 683-688

  Fotie, J ^a   Nkengfack, A E ^a   Rukunga, G ^b   Tolo, F ^b   Peter, M G ^c   Heydenreich, M ^c   Fomum, Z T ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c UNIVERSITY OF POTSDAM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIHYDROXYXANTHONE; 1,3,6,8 TETRAHYDROXYXANTHONE; 1,3,8 TRIHYDROXY 6 METHYLXANTHONE; NORLICHEXANTHONE; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; IN VIVO STUDY; MALARIA; MOUSE; NONHUMAN; OXYGENATION; PARASITEMIA; PLASMODIUM BERGHEI;

ANIMALS; ANTIMALARIALS; DRUG EVALUATION, PRECLINICAL; ERYTHROCYTES; FEMALE; MALARIA; MICE; MICE, INBRED BALB C; OXIDATION-REDUCTION; PLANT OILS; PLASMODIUM BERGHEI; QUININE; TREATMENT OUTCOME; XANTHONES;

ANIMALIA; PLASMODIUM BERGHEI; PROTOZOA;

EID: 0344984312     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349803225002390     Document Type: Article

References (19)

1. Armitage, P. & Berry, G. (1991). Statistical Methods in Medicinal Research. Oxford: Blackwell Scientific.
2. Batsanov, A., Brook, G., Holling, D. & Kenwright, A. (2000). Pyrolysis reactions of nonafluorobiphenyl-4-yl prop-2-enyl ether: a remarkable rearrangement reaction of an intramolecular Diels-Alder product. Journal of the Chemical Society, Perkin Transactions 1, 11, 1731-1734.
3. Christensen, S. B. & Kharazmi, A. (2001). Bioactive Compounds from Natural Sources. London: Taylor & Francis.
4. Fonteneau, N., Martin, P., Mondo, M., Ficheux, H. & Gesson, J. P. (2001). Synthesis of quinone and xanthone analogs of rhein. Tetrahedron, 57, 9131-9135.
5. Fotie, J., Nkengfack, A. E., Peter, M. G., Heydenreich, M. & Fomum, Z. T. (2003). Chemical constituents of the ethyl acetate extracts of the stem bark and fruits of Dichrostachys cinerea and of the roots of Parkia bicolor. Fitoterapia, in press.
6. Gessler, M. C., Tanner, M., Chollet, J., Nkunya, M. H. H. & Heinrich, M. (1995). Tanzanian medicinal plants used traditionally for the treatment of malaria: in vivo antimalarial and in vitro cytotoxicity activities. Phytotherapy Research, 9, 504-508.
7. Hatsuda, Y. & Kuyama, S. (1955). Metabolic products of Aspergillus versicolor. IV. The antibiotic of versicolorin and some hydroxyxanthone. Nippon Nogeikagaku Kaishi, 29, 14-20.
8. Ignatushchenko, M. V., Winter, R. W., Baechinger, H. P., Hinrichs, D. J. & Riscoe, M. K. (1997). Xanthones as antimalarial agents; studies of a possible mode of action. FEBS Letters, 409, 67-73.
9. Ignatuschenko, M. V., Winter, R. W. & Riscoe, M. K. (2000). Xanthones as antimalarial agents: stage specificity. American Journal of Tropical Medicine and Hygiene, 62, 77-81.
10. Kelly, J. X., Winter, R., Peyton, D. H., Hinrichs, D. J. & Riscoe, M. (2002). Optimization of xanthone for antimalarial activity: the 3,6-bis-ω-diethylaminoalkoxyxanthone series. Antimicrobial Agents and Chemotherapy, 46, 144-150.
11. Kurono, M., Yamakawa, H., Koshizaka, T., Suzuki, T., Kato, E., Iida, T., Ohishi, N. & Yagi, K. (1988). Dihydroxyxanthone-containing Plant Extracts for Inhibition of Binding of 5-α-Dihydrotestosterones to Androgen Receptors. European Patent Application EP-88-110140. München: European Patent Office.
12. Okenu, D. M. N. (1999). An integrated approach for malaria in Africa. Malaria and Infectious Diseases in Africa, 10, 10-13.
13. Nkengfack, A. E., Azebaze, G. A., Vardamides, J. C., Fomum, Z. T. & van Heerden, F. R. (2002a). A prenylated xanthone from Allanblackia floribunda. Phytochemistry, 60, 381-384.
14. Nkengfack, A. E., Mkounga, P., Meyer, M., Fomum, Z. T. & Bodo. B. (2002b). Globulixanthones C, D and E: three prenylated xanthones with antimicrobial properties from the root bark of Symphonia globulifera. Phytochemistry, 61, 181-187.
15. Peters, W., Portus, J. H. & Robinson, B. L. (1975). The chemotherapy of rodent malaria XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity. Annals of Tropical Medicine and Parasitology, 69, 155-171.
16. Suzuki, O., Katsumata, Y., Oya, M., Chari, V. M., Vermes, B., Warger, H. & Hostettmann, K. (1981). Inhibition of type A and type B monoamine oxidases by naturally occurring xanthones. Planta Medica, 42, 17-21.
17. Tona, L., Mesia, K., Ngimbi, N. P., Chrimwami, B., Okond'ahoka, Cimanga, K., de Bruyne, T., Apers, S., Hermans, N., Totte, J., Pieters, I. & Vlietinck, A. J. (2001). In-vivo antimalarial activity of Cassia occidentalis, Morinda morindoides and Phyllanthus niruri. Annals of Tropical Medicine and Parasitology, 95, 47-50.
18. Ungwitayatorn, J., Pickert, M. & Frahm, A. W. (1997). Quantitative structure-activity (QSAR) study of polyhydroxyxanthones. Pharmaceutica Acta Helvetiae, 72, 23-29.
19. Winter, R. W., Ignatushchenko, M., Ogundahunsi, O. A. T., Cornell, K. A., Oduola, A. M. J., Hinrichs, D. J. & Riscoe, M. K. (1997). Potentiation of an antimalarial oxidant drug. Antimicrobial Agents and Chemotherapy, 41, 1449-1454.